1/24
08:42 am
bmea
Biomea Fusion, Inc.'s (NASDAQ:BMEA) largest shareholders are retail investors with 55% ownership, institutions own 38% [Yahoo! Finance]
Medium
Report
Biomea Fusion, Inc.'s (NASDAQ:BMEA) largest shareholders are retail investors with 55% ownership, institutions own 38% [Yahoo! Finance]
1/19
08:26 am
bmea
Rodman & Renshaw Initiates Biomea Fusion (BMEA) at Buy with $8 Price Target [Yahoo! Finance]
Low
Report
Rodman & Renshaw Initiates Biomea Fusion (BMEA) at Buy with $8 Price Target [Yahoo! Finance]
1/13
10:58 am
bmea
Biomea Fusion (NASDAQ:BMEA) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
Medium
Report
Biomea Fusion (NASDAQ:BMEA) is now covered by analysts at Rodman & Renshaw. They set a "buy" rating and a $8.00 price target on the stock.
1/13
08:03 am
bmea
Biomea Fusion (NASDAQ:BMEA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
Neutral
Report
Biomea Fusion (NASDAQ:BMEA) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.
1/12
08:00 am
bmea
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
Low
Report
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones
12/17
07:16 am
bmea
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Low
Report
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
12/17
07:00 am
bmea
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/11
06:11 am
bmea
Insider Spends US$99k Buying More Shares In Biomea Fusion [Yahoo! Finance]
Low
Report
Insider Spends US$99k Buying More Shares In Biomea Fusion [Yahoo! Finance]
12/9
06:35 pm
bmea
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
High
Report
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025
12/5
07:00 am
bmea
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
Low
Report
Biomea Fusion Presents COVALENT-111 Study Results at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
12/1
05:32 pm
bmea
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
12/1
04:22 pm
bmea
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) [Yahoo! Finance]
Medium
Report
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC) [Yahoo! Finance]
12/1
04:10 pm
bmea
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
Medium
Report
Biomea Fusion Announces Oral Presentation of Icovamenib at the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease (WCIRDC)
12/1
04:05 pm
bmea
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
11/24
07:00 am
bmea
Biomea Fusion to Participate at Upcoming Investor Conferences
Neutral
Report
Biomea Fusion to Participate at Upcoming Investor Conferences